Literature DB >> 2892272

P-fimbriated Escherichia coli urinary tract infection: a clinical correlation.

K J Dowling1, J A Roberts, M B Kaack.   

Abstract

We designed a retrospective study to determine the incidence of P-fimbriated Escherichia coli in patients with asymptomatic bacteriuria, acute urethral syndrome, bacterial cystitis, acute pyelonephritis, possible acute pyelonephritis, and acute and chronic prostatitis. In addition, we compared the incidence in uncompromised vs compromised hosts, inpatients vs outpatients, and children vs adults. P-fimbriated E coli were isolated in more than 80% of uncompromised patients with either acute pyelonephritis or acute prostatitis. In clinically compromised patients having these disorders, the incidence dropped to approximately 30% (P less than .025). Neither age nor inpatient/outpatient status was a significant factor. We stress the importance of P-fimbriation as a virulence factor in acute pyelonephritis and acute prostatitis caused by E coli, though these diseases may be caused by less virulent organisms in compromised patients. Thus, patients with acute pyelonephritis or acute prostatitis caused by E coli negative for P-fimbriae probably should be considered compromised; the compromising factor should be determined as a guide to subsequent treatment.

Entities:  

Mesh:

Year:  1987        PMID: 2892272     DOI: 10.1097/00007611-198712000-00012

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract.

Authors:  Félix Millán-Rodríguez; J Palou; Anna Bujons-Tur; Mireia Musquera-Felip; Carlota Sevilla-Cecilia; Marc Serrallach-Orejas; Carlos Baez-Angles; Humberto Villavicencio-Mavrich
Journal:  World J Urol       Date:  2005-12-31       Impact factor: 4.226

2.  Attenuation of antibody response to acute pyelonephritis by treatment with antibiotics.

Authors:  D E Neal; M B Kaack; G Baskin; J A Roberts
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 3.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and Catheter-associated bacteriuria and from fecal samples.

Authors:  D M Guyer; J S Kao; H L Mobley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract.

Authors:  J A Roberts; B I Marklund; D Ilver; D Haslam; M B Kaack; G Baskin; M Louis; R Möllby; J Winberg; S Normark
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

6.  Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction.

Authors:  C Le Bouguenec; M Archambaud; A Labigne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

7.  Medical Device-Associated Candida Infections in a Rural Tertiary Care Teaching Hospital of India.

Authors:  Sachin C Deorukhkar; Santosh Saini
Journal:  Interdiscip Perspect Infect Dis       Date:  2016-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.